Atovaquone: An antiprotozoal drug, suppresses primary and resistant breast tumor growth by inhibiting HER2/β-catenin signaling

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume -, Issue -, Pages molcanther.1286.2018

出版商

American Association for Cancer Research (AACR)

发表日期

2019-07-04

DOI

10.1158/1535-7163.mct-18-1286

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started